The trademark lumen was filed by IPSEN PHARMA S.A.S, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on May 10, 2020, and received undefined oppositions.
Opposition Proceedings
There are undefined Oppositions claimed against trademark.
The first opposition filed on August 10, 2020 by Lumen Technologies, LLC on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by NOERR ALICANTE IP, S.L. and its proceedings were handled in English The second opposition filed on August 9, 2020 by COLOMA DEL PESO, JORGE on (a) Art. 8(4), (b) Likelihood of confusion. the opponent was represented by Santos Rodríguez, Sandra and its proceedings were handled in English The third opposition filed on August 2, 2020 by SenTec AG on Likelihood of confusion. the opponent was represented by isarpatent - Patent- und Rechtsanwälte Barth · Charles · Hassa · Peckmann & Partner mbB and its proceedings were handled in English
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).
Change of name and address of the trademark registration was recorded on January 11, 2022.
Goods And Services
The mark was filed in class 9 with following description of goods:
Downloadable software applications
Downloadable mobile applications for the transmission of information
Software for remote diagnostics
Pressure sensors
Temperature sensors
Connected bracelets [measuring instruments]
Wearable activity trackers
Health monitoring software
All the aforesaid goods being exclusively for patients suffering from renal cell carcinoma.
The mark was filed in class 10 with following description of goods:
Telemetry devices for medical applications
Electronic monitoring instruments for medical use
Physiological monitoring apparatus for medical use
Patient monitoring instruments
Medical instruments for therapeutic drug monitoring
All the aforesaid goods being exclusively for patients suffering from renal cell carcinoma.
The mark was filed in class 41 with following description of goods:
Medical education services
Publishing of medical publications
Advice relating to medical training
Conducting of educational seminars relating to medical matters
Publishing scientific papers in relation to medical technology
All the aforesaid services being exclusively for patients suffering from renal cell carcinoma.
The mark was filed in class 42 with following description of goods:
Software as a service [SaaS]
Platforms for artificial intelligence as software as a service [SaaS]
All the aforesaid services being exclusively for patients suffering from renal cell carcinoma.
The mark was filed in class 44 with following description of goods:
Medical assistance
Medical information
Medical diagnostic services
Medical evaluation services
Medical consultations
Monitoring of patients
Medical information retrieval services
Providing medical information
All the aforesaid services being exclusively for patients suffering from renal cell carcinoma.